Dr. Md Alamgir Kabir | Disease Diagnostics | Best Researcher Award
Sr Scientist at Beckman Coulter Diagnostics, United States
Dr. Md Alamgir Kabir is an accomplished researcher and scientist with extensive experience in bioengineering, microfluidics, and diagnostic assay development. With over eight years of experience in cross-functional research and technology transfer, Dr. Kabir has been at the forefront of medical diagnostics and point-of-care technologies. His work spans assay development, biosensor fabrication, and microfluidic device characterization, contributing significantly to advancements in viral diagnostics and public health. He has successfully led multiple research projects funded by prestigious organizations such as NIH, NSF, and FDOH, demonstrating expertise in laboratory automation and regulatory compliance.
Profile
Education
Dr. Kabir earned his Ph.D. in Electrical Engineering with a focus on Bioengineering from Florida Atlantic University in 2021. His dissertation, “Development of Point-of-Care Assays for Zika Virus Diagnostic,” laid the groundwork for novel diagnostic tools in infectious disease detection. Prior to his doctoral studies, he completed an M.Sc. in Electrical Engineering (Bioengineering) at the same institution in 2018. He began his academic journey with a Bachelor of Science in Electrical & Electronic Engineering from Rajshahi University of Engineering & Technology, Bangladesh, in 2013.
Experience
Dr. Kabir is currently a Senior Scientist at Beckman Coulter Diagnostics, where he leads cross-functional teams in reagent optimization, quality assurance, and product development. Previously, he worked at Ethos Biosciences, focusing on lateral flow immunoassays and new raw material integration. His tenure as an R&D Scientist at In Vitro Diagnostic Solutions saw him spearheading diagnostic assay development, securing major grants, and establishing a quality management system for regulatory compliance. During his graduate studies, he contributed to groundbreaking research in microfluidic biosensors and virus detection as a Research and Teaching Assistant at Florida Atlantic University.
Research Interests
Dr. Kabir’s research interests encompass microfluidics, biosensor development, and point-of-care diagnostics for infectious diseases. His work in lensless imaging and impedance-based biosensors has paved the way for portable, cost-effective diagnostic solutions. He has extensively studied the selection of antibody panels for Zika and Dengue virus detection, wastewater-based epidemiology for SARS-CoV-2 monitoring, and rheotaxis-based sperm selection in fertility treatments. His interdisciplinary approach integrates bioengineering, computational modeling, and analytical chemistry to drive innovations in disease diagnostics and healthcare technologies.
Awards and Honors
Dr. Kabir’s contributions to research and academia have been recognized through numerous awards and fellowships. He received the IRFP Fellowship from the Department of Labor, NJ State, in 2022, and multiple Graduate Fellowships for Academic Excellence from Florida Atlantic University. His research excellence earned him the Best Poster Award at FAU’s Graduate Research Day, and he was a People’s Choice Award winner at the Three Minute Thesis (3MT®) competition. Additionally, he was awarded the COVID-19 Response Award by the Institute of International Education and has received multiple Thesis and Dissertation Scholarships for outstanding doctoral research.
Publications
Hussein Zilouchian, Md Alamgir Kabir, et al. “Current and Future Diagnostics for Hepatitis C Virus Infection,” Chemosensors, 2025.
Rakib Ahmed Chowdhury, Md Alamgir Kabir, et al. “Effectiveness of Wastewater-Based Epidemiology as an Early Warning Tool to Detect SARS-CoV-2,” Health, 2024.
Robert Harper, Md Alamgir Kabir, et al. “The PreQuine Platform: A Novel Diagnostic Tool for G6PD Activity and Hemoglobin Concentration,” PLOS One, 2024.
Sandhya Sharma, Md Alamgir Kabir, et al. “Selection of Healthy Sperm Based on Positive Rheotaxis Using a Microfluidic Device,” Analyst, 2022.
Afrouz Ataei, Md Alamgir Kabir, et al. “Rheotaxis-Based Microfluidic Device for Selecting Sperm from Samples Infected with a Virus,” F&S Science, 2021.
Md Alamgir Kabir, Hussein Zilouchian, et al. “Dengue Detection: Advances in Diagnostics Tools from Conventional to Point-of-Care,” Biosensors, 2021.
Md Alamgir Kabir, Rajib Ahmed, et al. “Management of COVID-19: Current Status and Future Prospects,” Microbe and Infection, 2021.
Conclusion
Dr. Md Alamgir Kabir is a dedicated scientist whose research has significantly contributed to the fields of bioengineering, diagnostic assay development, and public health. His pioneering work in microfluidics and biosensors has facilitated the creation of accessible and efficient diagnostic tools. With a strong publication record, numerous awards, and leadership in innovative research projects, Dr. Kabir continues to drive advancements in medical diagnostics and healthcare technology, aiming to make a lasting impact on global health solutions.